Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Sell
35
ACRE Quote, Financials, Valuation and Earnings
Last price:
$6.17
Seasonality move
:
-8.3%
Day range:
$6.19 - $6.32
52-week range:
$6.02 - $11.24
Dividend yield:
17.12%
P/E ratio:
--
P/S ratio:
188.95x
P/B ratio:
0.61x
Volume:
321.4K
Avg. volume:
598.3K
1-year change:
-42.53%
Market cap:
$344.2M
Revenue:
$81.4M
EPS (TTM):
-$1.18
Analysts' Opinion
-
Consensus RatingAres Commercial Real Estate has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Ares Commercial Real Estate has an estimated upside of 10.94% from its current price of $6.31.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $6.31.
Fair Value
-
According to the consensus of 7 analysts, Ares Commercial Real Estate has 10.94% upside to fair value with a price target of -- per share.
ACRE vs. S&P 500
-
Over the past 5 trading days, Ares Commercial Real Estate has underperformed the S&P 500 by -6.71% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Ares Commercial Real Estate does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ares Commercial Real Estate revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Ares Commercial Real Estate reported revenues of $10.9M.
Earnings Growth
-
Ares Commercial Real Estate has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Ares Commercial Real Estate reported earnings per share of -$0.11.
Enterprise value:
1.6B
EV / Invested capital:
0.83x
Price / LTM sales:
188.95x
EV / EBIT:
27.74x
EV / Revenue:
876.92x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
41.27x
Price / Operating cash flow:
8.89x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-2.96%
Net Income Margin (TTM):
-3511.9%
Return On Equity:
-10.43%
Return On Invested Capital:
-3.01%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $108.7M | $95.3M | $1.8M | $19M | $10.9M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $0.91 | $0.06 | -$1.18 | $0.17 | -$0.11 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $81.3M | $65.9M | $239.2M | $194.3M | $113M | |
| Total Assets | $1.9B | $2.5B | $2.7B | $2.4B | $1.9B | |
| Current Liabilities | $804.9M | $677M | $873.2M | $678.8M | $19.6M | |
| Total Liabilities | $1.5B | $1.8B | $2B | $1.7B | $1.4B | |
| Total Equity | $469.3M | $672.7M | $767.1M | $683M | $563.8M | |
| Total Debt | $1.4B | $1.7B | $1.9B | $1.6B | $1.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $60.1M | $51.8M | $38.6M | $13.5M | $8.4M | |
| Cash From Investing | -$188.6M | $298.7M | $341.1M | -$47.7M | $121.5M | |
| Cash From Financing | $189.9M | -$366.8M | -$368.3M | -$47.4M | -$128.3M | |
| Free Cash Flow | $60.1M | $51.8M | $38.6M | $13.5M | $8.4M | |
ACRE
Sector
Market Cap
$344.2M
$700.3M
Price % of 52-Week High
56.14%
88.31%
Dividend Yield
17.12%
2.2%
Shareholder Yield
--
3.87%
1-Year Price Total Return
-42.53%
7.75%
Beta (5-Year)
1.484
0.737
Dividend yield:
17.12%
Annualized payout:
$1.36
Payout ratio:
-100.27%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$6.48
200-day SMA
Sell
Level
$7.01
Bollinger Bands (100)
Sell
Level
6.56 - 7.26
Chaikin Money Flow
Sell
Level
-24.7M
20-day SMA
Sell
Level
$6.87
Relative Strength Index (RSI14)
Sell
Level
36.47
ADX Line
Sell
Level
11.55
Williams %R
Neutral
Level
-76.8
50-day SMA
Sell
Level
$6.81
MACD (12, 26)
Sell
Level
-0.18
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Sell
Level
-16.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.0203)
Sell
CA Score
(Annual)
Level (-1.2884)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (1.4547)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.
Stock Forecast FAQ
In the current month, ACRE has received 0 Buy ratings 7 Hold ratings, and 0 Sell ratings. The ACRE average analyst price target in the past 3 months is --.
-
Where Will Ares Commercial Real Estate Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ares Commercial Real Estate share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Ares Commercial Real Estate?
Analysts are divided on their view about Ares Commercial Real Estate share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ares Commercial Real Estate is a Sell and believe this share price will drop from its current level to --.
-
What Is Ares Commercial Real Estate's Price Target?
The price target for Ares Commercial Real Estate over the next 1-year time period is forecast to be -- according to 7 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is ACRE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ares Commercial Real Estate is a Hold. 7 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of ACRE?
You can purchase shares of Ares Commercial Real Estate via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ares Commercial Real Estate shares.
-
What Is The Ares Commercial Real Estate Share Price Today?
Ares Commercial Real Estate was last trading at $6.17 per share. This represents the most recent stock quote for Ares Commercial Real Estate. Yesterday, Ares Commercial Real Estate closed at $6.31 per share.
-
How To Buy Ares Commercial Real Estate Stock Online?
In order to purchase Ares Commercial Real Estate stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 26
Power Solutions International [PSIX] is down 5.45% over the past day.
Buy
65
TSLL alert for Dec 26
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 3.71% over the past day.
Buy
75
SMLR alert for Dec 26
Semler Scientific [SMLR] is down 1.75% over the past day.
